Aspira Women's Health appoints John Ragard to Board of Directors

Aspira Women's Health Inc.

John Ragard appointed to board effective July 25, 2024; designated by stockholder Jack W. Schuler.
Ragard brings over 46 years of venture capital and public equity investment experience.
Currently Senior Investment Advisor at Wayve Capital; previously managed portfolios at Spouting Rock and Friess Associates.
Will serve as director until the company's 2025 annual meeting of stockholders.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John Ragard

director

AWHL · Aspira Women's Health Inc.

Effective: 2024-07-25
Filed: July 29, 2024, 7:59 PM ET

On July 29, 2024, Aspira Women’s Health Inc. (the “Company”) issued a press release announcing the appointment of John Ragard as a director, effective July 25, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John Ragard was appointed as director at Aspira Women's Health Inc..

Action: appointed
Role: director

Exact text from the filing

On July 29, 2024, Aspira Women’s Health Inc. (the “Company”) issued a press release announcing the appointment of John Ragard as a director, effective July 25, 2024.

View on SEC.gov

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-087276

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.